testosterone

Rising patient interest in TRT, GLP-1s, and peptide stacking requires clinicians to anchor conversations in evidence tiers, use baseline DEXA scans to monitor body composition, and engage patient goals without endorsing unsupported claims, according to Jean Cunningham, PharmD, BCPS...

* Treatment should be embedded in structured monitoring of hematocrit, blood pressure, renal and hepatic function, and cardiac rhythm, and coupled with active management of coexisting obesity, sleep apnea, diabetes, hypertension, and dyslipidemia, each of which independently influences AF risk...

He mentions Bhasin's latest paper when speaking about TT vs FT! https://www.excelmale.com/threads/hormonal-profiles-of-men-with-highly-elevated-shbg-and-primary-testicular-dysfunction-support-free-hormone-hypothesis.34791/ 45:34-58:43 (TT vs FT, estradiol/AI, hematocrit) In this...

Dr. Zitzmann * Testosterone is surrounded by myths, expectations and fears. It is neither a universal fountain of youth nor simply a dangerous “doping hormone”. It is an essential hormone whose deficiency can have significant consequences—but diagnosis and treatment must always be based on...

* Once treatment is indicated, clinicians should document the testosterone ester, dose, concentration, route, injection interval, timing of the last injection, and timing of bloodwork. Without that context, testosterone results can be misleading...

Two heavy weights in the field drop a big one! * Sixty-five years after the landmark publication by Huggins and Hodges, it was discovered that their principal conclusion that T injections “activated” PCa even in hormonally intact men was based on erratic acid phosphatase results in a single...

Dr. Justin Houman is a urologist and fellowship-trained Male Reproductive Medicine and Surgery specialist, whose practice is focused on men's health, include male hormone management, sexual and ejaculatory dysfunction, male fertility, male incontinence, and Peyronie's disease. As a...

* Dr. Khera explains why testosterone is one of the most biologically active hormones in the female body, with receptors in the brain, heart, bone, muscle, and genitalia, and why the research to prove its full benefits for women has simply never been funded. * He walks through what low...

In this episode, Dr. Brandon & Dr. Morgentaler talk about what high PSA levels really mean, their relationship to prostate cancer, and why an elevated PSA doesn’t necessarily rule out testosterone therapy after proper evaluation. Timestamps 00:00 PSA Basics Explained — PSA is a normal...

Hey Guys, On Nebido 1000mg 4ml every 8 weeks Normally week 2 to 6 feel great, nocturnal erections and erections at will. I'm now at nearly week 4, no erections at all, loss libido, so I got bloods done Testosterone = 25.7 nmol/L SHBG = 27 nmol/L Calculated free T ≈ 650 pmol/L Oestradiol = 205...

If erectile dysfunction, Low-T, or Peyronie’s disease are affecting your confidence, relationships, or quality of life, it’s time for answers. Join nationally recognized men’s sexual health expert Dr. Paurush Babbar on June 23 at 6 p.m. for a candid conversation about the latest treatments...

* “Active surveillance is about safely managing low-risk prostate cancer while preserving quality of life,” said Sanoj Punnen, M.D., professor of urologic oncology at the Miller School and DSUI vice chair of research. “For some men, maintaining quality of life may include testosterone...

Hi friends, I have been on TRT for 8 years. Started with hertoghe clinic in Belgium but after 2 years I quit because they where expensive as hell and they can't provide the optimal protocol. So I switched to BalanceMyHormones for 6 years and for me personally it was the best I could get. I...

Some of the true heavyweights here! Introduction General practitioners (GPs) are often the first point of contact for men with testosterone deficiency (TD), however, TD has traditionally been considered a condition reserved for specialists [1]. Various specialty societies have published...

https://endo2026.endocrine.org/fsPopup.asp?efp=RkVJT0NBS1UyNTg5OA&PresentationID=1845616&rnd=0.7988844&mode=presInfo Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major public health concern, affecting approximately one third of the adult population. While...

Dr. Snyder nuff said! 00:00-29:16 32:57-54:12

Dr. Stanton Honig. Been at this for decades! In today's health headlines: what to know about the recent changes to testosterone risk and use labels, what to know about testosterone screening, and how lifestyle habits could impact testosterone.

The Food and Drug Administration's (FDA) Office of Women's Health and the Center for Drug Evaluation and Research are announcing a public workshop titled "Testosterone Use in Menopausal Women." The purpose of the public workshop is to examine the current scientific evidence and critical...

* The primary aim of this study was to compare serum TT levels between patients treated with the standard once-daily regimen and those using a twice-daily split-dose schedule. Given the real-world and self-initiated nature of the dosing modification, the present study should be considered...

* Shalender Bhasin, MD, is a Professor of Medicine at Harvard Medical School, Director of the Boston Claude D. Pepper Aging Research Center, and Director of the Center for Clinical Investigation at Brigham and Women’s Hospital. He is an internationally recognized expert in testosterone biology...

* To get into the facts and fictions around testosterone, Brittany is joined by NPR health correspondent Will Stone (https://www.npr.org/people/919093243/...) , and Dr. Helen Bernie (https://iuhealth.org/find-providers/p...) , Director of Sexual and Reproductive Medicine and associate professor...

Hey guys, posting this for a friend who doesn’t speak English. He recently had a blood test and his testosterone came back at 2.18 ng/mL (7.56 nmol/L) which seems pretty low. He then had an online consultation with a doctor. During the consultation, the doctor told him to use Testotop...

Dr. Susan R Davis * We have absolutely no safety data about giving super high levels of testosterone to otherwise well women including women on hormone therapy, then people will say yeah but what about people who transgender, yes but the people who transgender are not on estrogen and...

* "One takeaway message from this is that ongoing engagement in a structured weight management program is extremely important for maintenance and the benefit of testosterone." Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at...

00:45:58 Why Semen Analysis Falls Short 01:12:26 Testosterone, Fertility-Safe Options, and Future Technology Dr. Alexander Pastuszak, leading urologist, fertility scientist, and biotech entrepreneur, dives deep into the science and future of male birth control, the truth about testosterone...

Abraham Morgentaler, MD, joins Neil Baum, MD, to discuss the historical origins of the belief that testosterone drives prostate cancer and the new framework presented in his recent Journal of Urology publication.

* She outlines key domains of dysfunction, including erectile dysfunction, ejaculatory disorders, low libido, and hypogonadism, and reviews how these may be assessed in a clinical setting. Helen L. Bernie, DO, MPH, Director, Sexual and Reproductive Medicine and Assistant Professor of...

https://stytiki-dysleitourgia.gr/en/?utm_source=chatgpt.com https://stytiki-dysleitourgia.gr/en/dimitris-hatzichristou/ https://stytiki-dysleitourgia.gr/en/the-secrets-of-a-good-erection/ https://www.excelmale.com/threads/testosterone-mens-sexual-health.31445/#post-290919

https://melanieavalon.com/testosterone/

* Chronic opioid use is a common but underappreciated cause of androgen deficiency in men. * Opioids suppress the gonadal axis mainly by inhibiting GnRH synthesis and secretion. The prevalence of opioid-induced androgen deficiency in men varies between 20% and 80% and is influenced by the type...

* T4DM RUNON sub-study extended the T4DM randomized, double-blind, placebo-controlled trial (n=1007) by 2 years, for a total of up to 4 years of treatment, without ongoing enrolment in the lifestyle program. Eligible and consenting participants (n=121) continued their original masked allocation...